| 1.39 Delayed Data As of Aug 22 |  -0.074 / -5.07%Today’s Change | 1.23 Today|||52-Week Range 8.50 | -49.23% Year-to-Date |
| Previous close | 1.46 |
| Today’s open | 1.46 |
| Day’s range | 1.32 - 1.46 |
| Volume | 69,566 |
| Average volume (3 months) | 73,842 |
| Market cap | $34.2M |
| Earnings growth (last year) | +48.32% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +59.03% |
| P/E ratio | NM |
| Price/Sales | 113.45 |
| Price/Book | 16.21 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $505.7K |
| Annual profit (last year) | -$4.1M |
| Net profit margin | -816.35% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, CEO, Secretary & Director David M. Tobias |
Chief Financial & Accounting Officer Donald J. Lundbom |
Corporate headquarters Mesquite, Nevada |
